6
Views
4
CrossRef citations to date
0
Altmetric
CaseReport Article

Neuroleptic malignant syndrome and risperidone: a case report

, &
Pages 419-421 | Published online: 11 May 2010

References

  • Ayd F. Fatal hyperpyrexia during treatment with chlorpromazine therapy. Journal of Clinical Psychiatry 1956; 27: 189–192
  • Delay J, Deniker P. Drug induced extra pyramidal syndrome. Handbook of clinical neurology. Vol. 6. New York: Elsevier, D Vinken, G Bruyen, 1968; 248–266
  • Pope H, Keck P, McElroy S. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry 1986; 143: 1227–1233
  • Levenson J. Neuroleptic malignant syndrome. American Journal of Psychiatry 1985; 142: 1137–1145
  • Reilly J, Crowe S, Lloyd J. Neuroleptic toxicity syndromes: a clinical spectrum. Australian and New Zealand Journal of Psychiatry 1991; 25: 499–505
  • Risperdal product information. Janssen-Cilag,. 1993
  • Lieberman J. Understanding the mechanism of action of atypical antipsychotic drugs. British Journal of Psychiatry 1993; 163: 7–18
  • Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry 1989; 146: 717–725
  • Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica 1986; 73: 337–347

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.